Back
2seventy bio Vs. Bristol-Myers Squibb Industry Stock Comparison
Sell
24
TSVT
2seventy bio
Last Price:
4.13
Seasonality Move:
21.15%
Buy
63
BMY
Bristol-Myers Squibb
Last Price:
58.43
Seasonality Move:
1.84%
Sell
24
2seventy bio (TSVT)
is a Sell
Is 2seventy bio a Buy, Sell or Hold?
- The current 2seventy bio [TSVT] share price is $4.28. The Score for TSVT is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- TSVT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Bristol-Myers Squibb (BMY)
is a Buy
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $59.02. The Score for BMY is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- BMY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TSVT Stock Price Chart
What is 2seventy bio's stock price today?
-
The 2seventy bio share price today is $4.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TSVT is experiencing selling pressure, which indicates risk of future bearish movement.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $59.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing selling pressure, which indicates risk of future bearish movement.
TSVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 38.56 | Sell |
| Chaikin Money Flow: | -280788 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.58 - 5.06) | Sell |
| Bollinger Bands (100): | (4.22 - 4.92) | Sell |
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.5 | Buy |
| Relative Strength Index (14 RSI): | 67.89 | Buy |
| Chaikin Money Flow: | -11233810 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.87 - 55.89) | Buy |
| Bollinger Bands (100): | (44.03 - 53.35) | Buy |
TSVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.65 | Sell |
| 20-day SMA: | 4.79 | Sell |
| 50-day SMA: | 4.75 | Sell |
| 200-day SMA: | 4.7 | Sell |
| 8-day EMA: | 4.63 | Sell |
| 20-day EMA: | 4.72 | Sell |
| 50-day EMA: | 4.72 | Sell |
| 200-day EMA: | 4.83 | Sell |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.09 | Buy |
| 20-day SMA: | 54.22 | Buy |
| 50-day SMA: | 52.18 | Buy |
| 200-day SMA: | 48.15 | Buy |
| 8-day EMA: | 56.43 | Buy |
| 20-day EMA: | 54.74 | Buy |
| 50-day EMA: | 52.47 | Buy |
| 200-day EMA: | 50.21 | Buy |
2seventy bio Earnings Growth & TSVT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.29 per share, and a decrease next year of $0.29 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.50 per share, and an increase next year of $6.16 per share.
2seventy bio Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bristol-Myers Squibb Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||